Refractory postoperative hiccups is an uncommon but distressing condition that may cause deleterious effects such as wound dehiscence, infection, fatigue, and dehydration. Hiccups–brief bursts of intense inspiratory activity involving the diaphragm and inspiratory intercostal muscles, with reciprocal inhibition of the expiratory intercostal muscles–might result from structural or functional disturbances of the medulla or of afferent or efferent nerves to the respiratory muscles (1). The first line of management is to reverse or treat any underlying cause such as esophageal obstruction or gastric distention. In most cases, hiccups respond to stimulation of the pharynx or the external auditory meatus, or to vagal maneuvers. Increasing the partial pressure of inspired carbon dioxide (rebreathing) reduces the frequency of hiccups, and reducing carbon dioxide pressure (hyperventilation) increases the amplitude of hiccups (2). Patients with persistent hiccups have been treated with several classes of drugs: chlorpromazine, carbamazepine, nifedipine, nimodipine, baclofen, metoclopramide, haloperidol, ketamine, phenytoin and lidocaine (2–4). All have potentially serious adverse effects and some may be contraindicated in the postoperative setting. Invasive techniques proposed for the control of refractory hiccups include glossopharyngeal nerve block (5) and phrenic nerve block (6). Both procedures reduce vital capacity, may cause dyspnea or hypoxia, and may fail to stop hiccups (7). We previously reported (8) that severe hiccups in medical patients responds to treatment with nefopam– 3,4,5,6-Tetrahydro-5-methyl-l-phenyl-1H-2.5-benoxazo-cine hydrochloride (Oxadol, Kedrion, Italy)–a nonopioid analgesic drug with shivering suppression properties (9). In this study we describe the use of nefopam in seven patients with postoperative hiccups refractory to standard therapeutic maneuvers: gastric decompression, vagal maneuvers (Valsalva maneuver, carotid and optic compression), pharynx and external auditory meatus stimulation, and carbon dioxide rebreathing. This series includes all cases of refractory postoperative hiccups we observed over the past 2 yr as anesthesiologists in a university hospital.

Bilotta, F., Pietropaoli, P., Rosa, G. (2001). Nefopam for refractory postoperative hiccups. ANESTHESIA AND ANALGESIA, 93(5), 1358-1360 [10.1097/00000539-200111000-00066].

Nefopam for refractory postoperative hiccups

Bilotta F;
2001-01-01

Abstract

Refractory postoperative hiccups is an uncommon but distressing condition that may cause deleterious effects such as wound dehiscence, infection, fatigue, and dehydration. Hiccups–brief bursts of intense inspiratory activity involving the diaphragm and inspiratory intercostal muscles, with reciprocal inhibition of the expiratory intercostal muscles–might result from structural or functional disturbances of the medulla or of afferent or efferent nerves to the respiratory muscles (1). The first line of management is to reverse or treat any underlying cause such as esophageal obstruction or gastric distention. In most cases, hiccups respond to stimulation of the pharynx or the external auditory meatus, or to vagal maneuvers. Increasing the partial pressure of inspired carbon dioxide (rebreathing) reduces the frequency of hiccups, and reducing carbon dioxide pressure (hyperventilation) increases the amplitude of hiccups (2). Patients with persistent hiccups have been treated with several classes of drugs: chlorpromazine, carbamazepine, nifedipine, nimodipine, baclofen, metoclopramide, haloperidol, ketamine, phenytoin and lidocaine (2–4). All have potentially serious adverse effects and some may be contraindicated in the postoperative setting. Invasive techniques proposed for the control of refractory hiccups include glossopharyngeal nerve block (5) and phrenic nerve block (6). Both procedures reduce vital capacity, may cause dyspnea or hypoxia, and may fail to stop hiccups (7). We previously reported (8) that severe hiccups in medical patients responds to treatment with nefopam– 3,4,5,6-Tetrahydro-5-methyl-l-phenyl-1H-2.5-benoxazo-cine hydrochloride (Oxadol, Kedrion, Italy)–a nonopioid analgesic drug with shivering suppression properties (9). In this study we describe the use of nefopam in seven patients with postoperative hiccups refractory to standard therapeutic maneuvers: gastric decompression, vagal maneuvers (Valsalva maneuver, carotid and optic compression), pharynx and external auditory meatus stimulation, and carbon dioxide rebreathing. This series includes all cases of refractory postoperative hiccups we observed over the past 2 yr as anesthesiologists in a university hospital.
2001
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MEDS-23/A - Anestesiologia
English
PHRENIC-NERVE BLOCK
Bilotta, F., Pietropaoli, P., Rosa, G. (2001). Nefopam for refractory postoperative hiccups. ANESTHESIA AND ANALGESIA, 93(5), 1358-1360 [10.1097/00000539-200111000-00066].
Bilotta, F; Pietropaoli, P; Rosa, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
bilotta pietropaoli rosa.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 33 kB
Formato Adobe PDF
33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/453023
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 10
social impact